Loading…
Sectoral / Thematic · Nippon India Mutual Fund · AMFI code 102431Nippon India Pharma Fund
Disclosed for 84 months, Sep 2019 to Aug 2026.Published as: NIPPON INDIA PHARMA FUND (An Open Ended Equity Scheme Investing In Pharma Sector)
Portfolio value
₹8,689 Cr
down ₹80 Cr vs Sep 2024
- Stocks held
- 33
- unchanged
- Top 10 weight
- 59.7%
- of the portfolio in its ten largest
- Cash & debt
- 4.4%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 9, trimmed 23
Nippon India Pharma Fund is an active equity fund in the Sectoral / Thematic category from Nippon India Mutual Fund. In October 2024 it disclosed 33 stocks worth ₹8,689 Cr, down ₹80 Cr from Sep 2024. Its largest positions were Sun Pharmaceutical Industries Limited (14.0%), Divi's Laboratories Limited (9.2%), Lupin Limited (8.1%); the ten largest together made up 59.7% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 78.7% of its equity. Cash and debt stood at 4.4%. Compared with Sep 2024 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
83%
Top-10 weight is higher than 83% of peers
Breadth
18%
Holds more stocks than 18% of peers
Cash
65%
Holds more cash than 65% of peers
Holdings in October 2024
Download CSVEvery line the fund disclosed, with the change against Sep 2024. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 13.95%
- Δ weight
- down 0.45 pts
- Value
- ₹1,212 Cr
- Δ value
- down ₹51 Cr
- Status
- Trimmed
- Weight
- 9.16%
- Δ weight
- up 0.77 pts
- Value
- ₹796 Cr
- Δ value
- up ₹60.3 Cr
- Status
- Added
- Weight
- 8.06%
- Δ weight
- up 0.06 pts
- Value
- ₹701 Cr
- Δ value
- down ₹1.3 Cr
- Status
- Held
- Weight
- 5.54%
- Δ weight
- down 0.31 pts
- Value
- ₹481 Cr
- Δ value
- down ₹31.7 Cr
- Status
- Trimmed
- Weight
- 5.24%
- Δ weight
- down 0.08 pts
- Value
- ₹456 Cr
- Δ value
- down ₹11.4 Cr
- Status
- Trimmed
- Weight
- 5.13%
- Δ weight
- down 0.26 pts
- Value
- ₹446 Cr
- Δ value
- down ₹26.6 Cr
- Status
- Trimmed
- Cash, TREPS & receivables
- Weight
- 4.43%
- Δ weight
- up 0.70 pts
- Value
- ₹385 Cr
- Δ value
- up ₹57.4 Cr
- Status
- Added
- Weight
- 3.48%
- Δ weight
- up 0.17 pts
- Value
- ₹302 Cr
- Δ value
- up ₹11.9 Cr
- Status
- Added
- Weight
- 3.38%
- Δ weight
- down 0.12 pts
- Value
- ₹294 Cr
- Δ value
- down ₹13.1 Cr
- Status
- Trimmed
- Weight
- 2.89%
- Δ weight
- up 0.15 pts
- Value
- ₹251 Cr
- Δ value
- up ₹11 Cr
- Status
- Added
- Weight
- 2.88%
- Δ weight
- up 0.01 pts
- Value
- ₹250 Cr
- Δ value
- down ₹1.6 Cr
- Status
- Trimmed
- Weight
- 2.85%
- Δ weight
- down 0.22 pts
- Value
- ₹248 Cr
- Δ value
- down ₹21.7 Cr
- Status
- Trimmed
- Weight
- 2.77%
- Δ weight
- up 0.18 pts
- Value
- ₹240 Cr
- Δ value
- up ₹13.2 Cr
- Status
- Added
- Weight
- 2.74%
- Δ weight
- down 0.10 pts
- Value
- ₹238 Cr
- Δ value
- down ₹10.9 Cr
- Status
- Trimmed
- Weight
- 2.60%
- Δ weight
- down 0.01 pts
- Value
- ₹226 Cr
- Δ value
- down ₹3.2 Cr
- Status
- Trimmed
- Weight
- 2.36%
- Δ weight
- up 0.01 pts
- Value
- ₹205 Cr
- Δ value
- down ₹1.2 Cr
- Status
- Trimmed
- Weight
- 2.31%
- Δ weight
- down 0.13 pts
- Value
- ₹200 Cr
- Δ value
- down ₹13.5 Cr
- Status
- Trimmed
- Weight
- 2.20%
- Δ weight
- up 0.06 pts
- Value
- ₹191 Cr
- Δ value
- up ₹3.3 Cr
- Status
- Added
- Weight
- 1.90%
- Δ weight
- up 0.27 pts
- Value
- ₹165 Cr
- Δ value
- up ₹21.7 Cr
- Status
- Added
- Weight
- 1.87%
- Δ weight
- down 0.21 pts
- Value
- ₹162 Cr
- Δ value
- down ₹19.9 Cr
- Status
- Trimmed
- Weight
- 1.86%
- Δ weight
- down 0.09 pts
- Value
- ₹161 Cr
- Δ value
- down ₹9.8 Cr
- Status
- Trimmed
- Weight
- 1.85%
- Δ weight
- down 0.07 pts
- Value
- ₹160 Cr
- Δ value
- down ₹7.6 Cr
- Status
- Trimmed
- Weight
- 1.80%
- Δ weight
- down 0.05 pts
- Value
- ₹156 Cr
- Δ value
- down ₹5.9 Cr
- Status
- Trimmed
- Weight
- 1.65%
- Δ weight
- up 0.04 pts
- Value
- ₹144 Cr
- Δ value
- up ₹2.2 Cr
- Status
- Added
- Weight
- 1.21%
- Δ weight
- down 0.02 pts
- Value
- ₹105 Cr
- Δ value
- down ₹2.6 Cr
- Status
- Trimmed
- Weight
- 1.11%
- Δ weight
- down 0.04 pts
- Value
- ₹96.8 Cr
- Δ value
- down ₹4.3 Cr
- Status
- Trimmed
- Weight
- 1.05%
- Δ weight
- up 0.07 pts
- Value
- ₹90.8 Cr
- Δ value
- up ₹5.6 Cr
- Status
- Added
- Weight
- 1.04%
- Δ weight
- down 0.19 pts
- Value
- ₹90 Cr
- Δ value
- down ₹17.3 Cr
- Status
- Trimmed
- Weight
- 0.66%
- Δ weight
- down 0.09 pts
- Value
- ₹57 Cr
- Δ value
- down ₹8.8 Cr
- Status
- Trimmed
- Weight
- 0.56%
- Δ weight
- down 0.02 pts
- Value
- ₹48.9 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 0.50%
- Δ weight
- down 0.01 pts
- Value
- ₹43.2 Cr
- Δ value
- down ₹91 L
- Status
- Trimmed
- Weight
- 0.47%
- Δ weight
- up 0.04 pts
- Value
- ₹40.5 Cr
- Δ value
- up ₹2.8 Cr
- Status
- Added
- Weight
- 0.29%
- Δ weight
- down <0.01 pts
- Value
- ₹25.2 Cr
- Δ value
- down ₹54 L
- Status
- Trimmed
- Weight
- 0.24%
- Δ weight
- down 0.02 pts
- Value
- ₹20.5 Cr
- Δ value
- down ₹2.3 Cr
- Status
- Trimmed
What changed, Sep 2024 to Oct 2024
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Divi's Laboratories Limitedup ₹60.3 Cr (+0.77% pts)
- Thyrocare Technologies Limitedup ₹21.7 Cr (+0.27% pts)
- Mankind Pharma Limitedup ₹13.2 Cr (+0.18% pts)
- Vijaya Diagnostic Centre Limitedup ₹11.9 Cr (+0.17% pts)
- JB Chemicals & Pharmaceuticals Limited ₹11 Cr (+0.15% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2024, the weight rose most in Healthcare Services (+0.4 pts), and fell most in Pharmaceuticals & Biotechnology (−0.3 pts).
- Healthcare Services17.8% → 18.2%+0.4 pts
- Pharmaceuticals & Biotechnology79.0% → 78.7%−0.3 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2021 | Oct 2023 | Apr 2024 | Jul 2024 | Sep 2024 | Oct 2024 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 76.2% | 77.2% | 79.0% | 79.2% | 79.0% | 78.7% |
| Healthcare Services | 21.6% | 17.0% | 17.0% | 17.4% | 17.8% | 18.2% |
| Retailing | — | 4.6% | 3.1% | 2.6% | 2.4% | 2.5% |
| Pharmaceuticals | 2.2% | 1.1% | 0.9% | 0.8% | 0.8% | 0.7% |
Allocation in Oct 2024change vs Sep 2024
- Pharmaceuticals & Biotechnology (22)78.7%▼ 0.3 pts
- Healthcare Services (9)18.2%▲ 0.4 pts
- Retailing (1)2.5%
- Pharmaceuticals (1)
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Oct 2024
4.4%
▲ 0.7 pts vs Sep 2024
- Cash alone
- 4.4%
- cash and net receivables
- A year earlier
- 3.9%
- Oct 2023 · now ▲ 0.5 pts
- Last 12 months
- 0.5% – 4.4%
- lowest to highest · record 5.9% in May 2021
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.